318 related articles for article (PubMed ID: 28591637)
1. Amino Acid Transporter Slc38a5 Controls Glucagon Receptor Inhibition-Induced Pancreatic α Cell Hyperplasia in Mice.
Kim J; Okamoto H; Huang Z; Anguiano G; Chen S; Liu Q; Cavino K; Xin Y; Na E; Hamid R; Lee J; Zambrowicz B; Unger R; Murphy AJ; Xu Y; Yancopoulos GD; Li WH; Gromada J
Cell Metab; 2017 Jun; 25(6):1348-1361.e8. PubMed ID: 28591637
[TBL] [Abstract][Full Text] [Related]
2. Angptl4 does not control hyperglucagonemia or α-cell hyperplasia following glucagon receptor inhibition.
Okamoto H; Cavino K; Na E; Krumm E; Kim S; Stevis PE; Harp J; Murphy AJ; Yancopoulos GD; Gromada J
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2747-2752. PubMed ID: 28143927
[TBL] [Abstract][Full Text] [Related]
3. Increased SLC38A4 Amino Acid Transporter Expression in Human Pancreatic α-Cells After Glucagon Receptor Inhibition.
Kim J; Dominguez Gutierrez G; Xin Y; Cavino K; Sung B; Sipos B; Kloeppel G; Gromada J; Okamoto H
Endocrinology; 2019 May; 160(5):979-988. PubMed ID: 30938753
[TBL] [Abstract][Full Text] [Related]
4. Disruption of glucagon receptor signaling causes hyperaminoacidemia exposing a possible liver-alpha-cell axis.
Galsgaard KD; Winther-Sørensen M; Ørskov C; Kissow H; Poulsen SS; Vilstrup H; Prehn C; Adamski J; Jepsen SL; Hartmann B; Hunt J; Charron MJ; Pedersen J; Wewer Albrechtsen NJ; Holst JJ
Am J Physiol Endocrinol Metab; 2018 Jan; 314(1):E93-E103. PubMed ID: 28978545
[TBL] [Abstract][Full Text] [Related]
5. Elevated Serum Amino Acids Induce a Subpopulation of Alpha Cells to Initiate Pancreatic Neuroendocrine Tumor Formation.
Smith DK; Kates L; Durinck S; Patel N; Stawiski EW; Kljavin N; Foreman O; Sipos B; Solloway MJ; Allan BB; Peterson AS
Cell Rep Med; 2020 Aug; 1(5):100058. PubMed ID: 33205067
[TBL] [Abstract][Full Text] [Related]
6. Interrupted Glucagon Signaling Reveals Hepatic α Cell Axis and Role for L-Glutamine in α Cell Proliferation.
Dean ED; Li M; Prasad N; Wisniewski SN; Von Deylen A; Spaeth J; Maddison L; Botros A; Sedgeman LR; Bozadjieva N; Ilkayeva O; Coldren A; Poffenberger G; Shostak A; Semich MC; Aamodt KI; Phillips N; Yan H; Bernal-Mizrachi E; Corbin JD; Vickers KC; Levy SE; Dai C; Newgard C; Gu W; Stein R; Chen W; Powers AC
Cell Metab; 2017 Jun; 25(6):1362-1373.e5. PubMed ID: 28591638
[TBL] [Abstract][Full Text] [Related]
7. Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia: evidence for a circulating α-cell growth factor.
Longuet C; Robledo AM; Dean ED; Dai C; Ali S; McGuinness I; de Chavez V; Vuguin PM; Charron MJ; Powers AC; Drucker DJ
Diabetes; 2013 Apr; 62(4):1196-205. PubMed ID: 23160527
[TBL] [Abstract][Full Text] [Related]
8. Glucagon cell hyperplasia and neoplasia: a recently recognized endocrine receptor disease.
Sipos B; Klöppel G
Endocr Relat Cancer; 2023 Aug; 30(8):. PubMed ID: 37260318
[TBL] [Abstract][Full Text] [Related]
9. Glucagon and Amino Acids Are Linked in a Mutual Feedback Cycle: The Liver-α-Cell Axis.
Holst JJ; Wewer Albrechtsen NJ; Pedersen J; Knop FK
Diabetes; 2017 Feb; 66(2):235-240. PubMed ID: 28108603
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of glucagon and glucagon-like peptide 1 receptors in mouse pancreatic alpha and beta cells in two models of alpha cell hyperplasia.
Kedees MH; Grigoryan M; Guz Y; Teitelman G
Mol Cell Endocrinol; 2009 Nov; 311(1-2):69-76. PubMed ID: 19647035
[TBL] [Abstract][Full Text] [Related]
11. Deleterious mutation V369M in the mouse GCGR gene causes abnormal plasma amino acid levels indicative of a possible liver-α-cell axis.
Liu Q; Lin G; Chen Y; Feng W; Xu Y; Lyu J; Yang D; Wang MW
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34002801
[TBL] [Abstract][Full Text] [Related]
12. Evidence of the receptor-mediated influence of melatonin on pancreatic glucagon secretion via the Gαq protein-coupled and PI3K signaling pathways.
Bähr I; Mühlbauer E; Albrecht E; Peschke E
J Pineal Res; 2012 Nov; 53(4):390-8. PubMed ID: 22672634
[TBL] [Abstract][Full Text] [Related]
13. Hyperaminoacidemia induces pancreatic α cell proliferation via synergism between the mTORC1 and CaSR-Gq signaling pathways.
Gong Y; Yang B; Zhang D; Zhang Y; Tang Z; Yang L; Coate KC; Yin L; Covington BA; Patel RS; Siv WA; Sellick K; Shou M; Chang W; Danielle Dean E; Powers AC; Chen W
Nat Commun; 2023 Jan; 14(1):235. PubMed ID: 36646689
[TBL] [Abstract][Full Text] [Related]
14. A Primary Role for α-Cells as Amino Acid Sensors.
Dean ED
Diabetes; 2020 Apr; 69(4):542-549. PubMed ID: 31653720
[TBL] [Abstract][Full Text] [Related]
15. Amino acid transporter SLC38A5 is a tumor promoter and a novel therapeutic target for pancreatic cancer.
Sniegowski T; Rajasekaran D; Sennoune SR; Sunitha S; Chen F; Fokar M; Kshirsagar S; Reddy PH; Korac K; Mahmud Syed M; Sharker T; Ganapathy V; Bhutia YD
Sci Rep; 2023 Oct; 13(1):16863. PubMed ID: 37803043
[TBL] [Abstract][Full Text] [Related]
16. Islets of Langerhans from prohormone convertase-2 knockout mice show α-cell hyperplasia and tumorigenesis with elevated α-cell neogenesis.
Jones HB; Reens J; Brocklehurst SR; Betts CJ; Bickerton S; Bigley AL; Jenkins RP; Whalley NM; Morgan D; Smith DM
Int J Exp Pathol; 2014 Feb; 95(1):29-48. PubMed ID: 24456331
[TBL] [Abstract][Full Text] [Related]
17. Glucagon receptor inactivation leads to α-cell hyperplasia in zebrafish.
Li M; Dean ED; Zhao L; Nicholson WE; Powers AC; Chen W
J Endocrinol; 2015 Nov; 227(2):93-103. PubMed ID: 26446275
[TBL] [Abstract][Full Text] [Related]
18. Homozygous P86S mutation of the human glucagon receptor is associated with hyperglucagonemia, alpha cell hyperplasia, and islet cell tumor.
Zhou C; Dhall D; Nissen NN; Chen CR; Yu R
Pancreas; 2009 Nov; 38(8):941-6. PubMed ID: 19657311
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic α-cell hyperplasia and hyperglucagonemia due to a glucagon receptor splice mutation.
Larger E; Wewer Albrechtsen NJ; Hansen LH; Gelling RW; Capeau J; Deacon CF; Madsen OD; Yakushiji F; De Meyts P; Holst JJ; Nishimura E
Endocrinol Diabetes Metab Case Rep; 2016; 2016():. PubMed ID: 27933176
[TBL] [Abstract][Full Text] [Related]
20. Loss of mTORC1 signaling alters pancreatic α cell mass and impairs glucagon secretion.
Bozadjieva N; Blandino-Rosano M; Chase J; Dai XQ; Cummings K; Gimeno J; Dean D; Powers AC; Gittes GK; Rüegg MA; Hall MN; MacDonald PE; Bernal-Mizrachi E
J Clin Invest; 2017 Dec; 127(12):4379-4393. PubMed ID: 29106387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
